Article

New model femtosecond laser available

IntraLase Corp. has introduced its new IntraLase FS30 laser, and patients and surgeons alike are benefiting from its faster procedure time, tighter spot placement, and lower energy compared with its predecessor, the IntraLase FS.

IntraLase Corp. has introduced its new IntraLase FS30 laser, and patients and surgeons alike are benefiting from its faster procedure time, tighter spot placement, and lower energy compared with its predecessor, the IntraLase FS.

Operating at 30 instead of 15 kHz, the FS30 femtosecond laser can be used to create a LASIK flap in less than 30 seconds. The reduced procedure time has positive implications for patients and surgical efficiency.

"The time it takes me to create a flap with this new laser has been cut in half and now averages in the 27- to 29-second range," said Tom I. Tooma, MD, medical director for all TLC Laser Eye Centers in California. "This shortened procedure is more comfortable for patients, but also enhances patient throughput, a benefit that is particularly important for a busy surgical center."

"Now the duration during which IOP is elevated is comparable to that associated with use of a conventional microkeratome," Dr. Tooma said. "However, the laser flap procedure is much safer because the suction pressure used and amount of IOP elevation occurring is much lower."

With the speed of the laser doubled, it has become possible to reduce the raster separation as well as the spot separation. Those features translate into superior dissection quality that enables flap elevation.

"Raising the flap is now extremely easy and not much different from elevating a flap created with a mechanical microkeratome," Dr. Tooma said.

The IntraLase FS30 operates using an energy of as little as 0.7 mJ compared with more than 1.3 mJ using the original system. The benefits of that feature include a reduced potential for postoperative inflammatory response as well as a smoother intracorneal surface.

"Using the new FS30 laser, the incidences of DLK and flap edema are minimized and so my 1-day UCVA outcomes are consistently excellent," Dr. Tooma said. "For most patients, UCVA on the first day after surgery is 20/15 or 20/20."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.